Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemoglobin H Disease”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Not applicableLooking for participantsNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Early research (Phase 1)Ended earlyNCT02986698
What this trial is testing

In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM)

Who this might be right for
Alpha Thalassemia MajorHemoglobinopathy; With ThalassemiaHemoglobinopathies+6 more
University of California, San Francisco 6
Not applicableStudy completedNCT00159029
What this trial is testing

Genetics of Alpha Thalassemia in Israeli Ethnic Groups

Who this might be right for
Alpha Thalassemia
Deborah Rund 100
Not applicableStudy completedNCT06831799
What this trial is testing

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Who this might be right for
HemoglobinopathiesSickle Cell DiseaseSickle Cell Anemia+21 more
Hospital Universitari Vall d'Hebron Research Institute 684
Not applicableStudy completedNCT00971984
What this trial is testing

Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern Israel

Who this might be right for
Thalassemia AlphaHemolytic Anemia
HaEmek Medical Center, Israel 50
Not applicableActive Not RecruitingNCT03412760
What this trial is testing

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Who this might be right for
Hydrops FetalisBirth DefectFetal Anomaly
University of California, San Francisco 500
Testing effectiveness (Phase 2)Study completedNCT04987489
What this trial is testing

Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseThalassemia
Forma Therapeutics, Inc. 53
Not applicableLooking for participantsNCT05799118
What this trial is testing

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia Alpha+1 more
Cyprus Institute of Neurology and Genetics 30,000
Testing effectiveness (Phase 2)Study completedNCT00873041
What this trial is testing

Efficacy and Safety of Deferasirox in Non-transfusion Dependent Thalassemia Patients With Iron Overload and a One Year Open-label Extension Study

Who this might be right for
Non-transfusion Dependent Thalassemia
Novartis Pharmaceuticals 166
Not applicableEnrolling By InvitationNCT05528796
What this trial is testing

Uncovering the Etiologies of Non-immune Hydrops Fetalis

Who this might be right for
Non-Immune Hydrops Fetalis
University of California, San Francisco 500
Large-scale testing (Phase 3)Not Yet RecruitingNCT07517133
What this trial is testing

Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia

Who this might be right for
Non-Transfusion-dependent Alpha-ThalassemiaNon-Transfusion-dependent Beta-Thalassemia
Agios Pharmaceuticals, Inc. 45
Not applicableLooking for participantsNCT06213402
What this trial is testing

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)

Who this might be right for
Sickle Cell DiseaseThalassemiaHemolytic; Anemia, Hereditary, Due to Enzyme Disorder+6 more
Hospital Universitari Vall d'Hebron Research Institute 32,564
Not applicableLooking for participantsNCT03775954
What this trial is testing

Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

Who this might be right for
High Risk PregnancyCongenital Heart DiseaseFetal Hydrops+16 more
Medical College of Wisconsin 30
Not applicableEnded earlyNCT00143039
What this trial is testing

Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR

Who this might be right for
Hydrops FetalisFetal Growth Retardation
Obstetrix Medical Group 48
Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05664737
What this trial is testing

Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia

Who this might be right for
Anemia
Bristol-Myers Squibb 189
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableLooking for participantsNCT04872179
What this trial is testing

International Registry of Patients With Alpha Thalassemia

Who this might be right for
Alpha-ThalassemiaAlpha Thalassemia MajorAlpha Thalassemia Minor
University of California, San Francisco 500
Large-scale testing (Phase 3)Active Not RecruitingNCT04770779
What this trial is testing

A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)

Who this might be right for
Transfusion-dependent Alpha-ThalassemiaTransfusion-dependent Beta-Thalassemia
Agios Pharmaceuticals, Inc. 258
Not applicableUnknownNCT02956564
What this trial is testing

Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment

Who this might be right for
Fetal Hydrops
Shanghai First Maternity and Infant Hospital 144
Load More Results